Paul F. Lizzul
Chief Medical Officer · 5 filings · Latest: Aug 15, 2026
ANAPTYSBIO, INC
First Tracks Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ANAB | Paul F. Lizzul | — | Jan 8, 2026 | Proposed Sale | $45.21 | 3,650 | $165.0K | — | |
ANAB | Paul F. Lizzul | — | Jan 7, 2026 | Proposed Sale | $43.91 | 2,235 | $98.1K | — | |
ANAB | Paul F. Lizzul | — | Jan 5, 2026 | Proposed Sale | $44.95 | 4,219 | $189.6K | — | |
ANAB | PAUL F LIZZUL | — | Dec 22, 2025 | Proposed Sale | $50.00 | 1,500 | $75.0K | — | |
ANAB | PAUL F LIZZUL | — | Sep 23, 2024 | Proposed Sale | $38.67 | 1,500 | $58.0K | — |